Serious Side Effects and Risks
While mild digestive issues are expected, there are rare but serious risks associated with taking tirzepatide. It is vital to be aware of these so you can seek emergency care if necessary.
Pancreatitis
Inflammation of the pancreas is a known risk for GLP-1 and GIP receptor agonists. If you feel severe pain in your upper stomach that radiates to your back, with or without vomiting, stop taking the medication and seek help immediately.
Gallbladder Problems
Rapid weight loss - regardless of how it is achieved - can lead to gallbladder issues, including gallstones. Symptoms include pain in the upper right abdomen, yellowing of the skin or eyes (jaundice), and clay-colored stools.
Kidney Issues
Severe nausea, vomiting, and diarrhoea can lead to dehydration, which may cause kidney damage or worsen existing kidney failure.
Low Blood Sugar (Hypoglycemia)
While Mounjaro alone usually does not cause low blood sugar, the risk increases if you take it alongside other medications that lower blood sugar, such as insulin or sulfonylureas.
Stomach Paralysis (Gastroparesis)
Because the drug works by slowing digestion, there have been reports of severe gastroparesis, where the stomach stops moving food into the small intestine effectively. This can cause persistent vomiting and requires medical intervention.
Boxed Warning: Thyroid C-Cell Tumours
The FDA has included a "boxed warning" (the strongest safety warning) for Mounjaro regarding thyroid C-cell tumours. In animal studies, tirzepatide caused thyroid tumours in rats. It is not yet known if Mounjaro causes these tumours in humans, but you should not take this medication if you have a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).